News & Updates
Filter by Specialty:
Vunakizumab safe, effective in moderate-to-severe plaque psoriasis
20 Jun 2022
Treatment with vunakizumab, a novel interleukin 17A monoclonal antibody, shows promise for moderate-to-severe plaque psoriasis and good tolerability, according to the results of a recent study.
Vunakizumab safe, effective in moderate-to-severe plaque psoriasis
20 Jun 2022
Antibiotic use for chronic endometritis poses risk of miscarriage after ART
20 Jun 2022
The use of antibiotic therapy to resolve chronic endometritis can put women undergoing assisted reproductive treatment (ART) at heightened risk of pregnancy loss, according to a study.
Antibiotic use for chronic endometritis poses risk of miscarriage after ART
20 Jun 2022
Change in serum marker levels tied to outcomes of RA-related interstitial lung disease
19 Jun 2022
In rheumatoid arthritis-related interstitial lung disease (RA-ILD), change over time in the levels of serum proteins, such as matrix metallopeptidase 13 (MMP13) and C-X-C motif ligand chemokine 11 (CXCL11), predict clinical outcomes, a recent study has found. The same is true for baseline clinical factors such as patient age and rheumatoid factor.
